Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Germana Falcone

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Molecular Therapy. Nucleic Acids|December 17, 2017
CRISPR/Cas9-Mediated Deletion of CTG Expansions Recovers Normal Phenotype in Myogenic Cells Derived from Myotonic Dystrophy 1 PatientsClaudia Provenzano, Marisa Cappella, Rea Valaperta, et al.
Oncogene|November 14, 2003
v-Src inhibits myogenic differentiation by interfering with the regulatory network of muscle-specific transcriptional activators at multiple levelsGermana Falcone, Laura Ciuffini, Maria-Cristina Gauzzi, et al.
Journal of Neuromuscular Diseases|January 14, 2026
Translational behavioral phenotypes in DMSXL mice for CNS manifestations of DM1Elisabetta Golini, Aline Huguet-Lachon, Hélène Benyamine, et al.
Aging Cell|November 22, 2012
Cytogenetic analysis of human cells reveals specific patterns of DNA damage in replicative and oncogene-induced senescenceGermana Falcone, Alessia Mazzola, Flavia Michelini, et al.
Computational and Structural Biotechnology Journal|December 28, 2020
Design of novel small molecule base-pair recognizers of toxic CUG RNA transcripts characteristics of DM1Raul Ondono, Ángel Lirio, Carlos Elvira, et al.
Cell Death & Disease|June 30, 2018
High-throughput analysis of the RNA-induced silencing complex in myotonic dystrophy type 1 patients identifies the dysregulation of miR-29c and its target ASB2Marisa Cappella, Alessandra Perfetti, Beatrice Cardinali, et al.
Molecular Therapy. Nucleic Acids|September 2, 2025
circARHGAP10 as a candidate biomarker and therapeutic target in myotonic dystrophy type 1Denisa Baci, Spyros Tastsoglou, Claudia Provenzano, et al.
Biomedicines|August 26, 2022
miRNome and Proteome Profiling of Small Extracellular Vesicles Secreted by Human Glioblastoma Cell Lines and Primary Cancer Stem CellsIngrid Cifola, Federica Fratini, Beatrice Cardinali, et al.
Aging Cell|May 8, 2013
Prolonged lifespan with enhanced exploratory behavior in mice overexpressing the oxidized nucleoside triphosphatase hMTH1Gabriele De Luca, Ilenia Ventura, Valentina Sanghez, et al.
International Journal of Molecular Sciences|April 24, 2019
Dysregulation of Circular RNAs in Myotonic Dystrophy Type 1Christine Voellenkle, Alessandra Perfetti, Matteo Carrara, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Molecular Therapy. Nucleic Acids|December 17, 2017
CRISPR/Cas9-Mediated Deletion of CTG Expansions Recovers Normal Phenotype in Myogenic Cells Derived from Myotonic Dystrophy 1 PatientsClaudia Provenzano, Marisa Cappella, Rea Valaperta, et al.
Oncogene|November 14, 2003
v-Src inhibits myogenic differentiation by interfering with the regulatory network of muscle-specific transcriptional activators at multiple levelsGermana Falcone, Laura Ciuffini, Maria-Cristina Gauzzi, et al.
Journal of Neuromuscular Diseases|January 14, 2026
Translational behavioral phenotypes in DMSXL mice for CNS manifestations of DM1Elisabetta Golini, Aline Huguet-Lachon, Hélène Benyamine, et al.
Aging Cell|November 22, 2012
Cytogenetic analysis of human cells reveals specific patterns of DNA damage in replicative and oncogene-induced senescenceGermana Falcone, Alessia Mazzola, Flavia Michelini, et al.
Computational and Structural Biotechnology Journal|December 28, 2020
Design of novel small molecule base-pair recognizers of toxic CUG RNA transcripts characteristics of DM1Raul Ondono, Ángel Lirio, Carlos Elvira, et al.
Cell Death & Disease|June 30, 2018
High-throughput analysis of the RNA-induced silencing complex in myotonic dystrophy type 1 patients identifies the dysregulation of miR-29c and its target ASB2Marisa Cappella, Alessandra Perfetti, Beatrice Cardinali, et al.
Molecular Therapy. Nucleic Acids|September 2, 2025
circARHGAP10 as a candidate biomarker and therapeutic target in myotonic dystrophy type 1Denisa Baci, Spyros Tastsoglou, Claudia Provenzano, et al.
Biomedicines|August 26, 2022
miRNome and Proteome Profiling of Small Extracellular Vesicles Secreted by Human Glioblastoma Cell Lines and Primary Cancer Stem CellsIngrid Cifola, Federica Fratini, Beatrice Cardinali, et al.
Aging Cell|May 8, 2013
Prolonged lifespan with enhanced exploratory behavior in mice overexpressing the oxidized nucleoside triphosphatase hMTH1Gabriele De Luca, Ilenia Ventura, Valentina Sanghez, et al.
International Journal of Molecular Sciences|April 24, 2019
Dysregulation of Circular RNAs in Myotonic Dystrophy Type 1Christine Voellenkle, Alessandra Perfetti, Matteo Carrara, et al.
Pageof 3